Report Categories
View AllRecent Articles
View All
Johnson Johnson JNJ Tapped as Defensive LargeCap Healthcare Pick Amid Peer Rotation Recommendations
How Xos XOS pricing power shows up in earnings XOS Q4 2025 Earnings Miss as Loss Widens
BFS Saul Centers posts 45 Q4 2025 EPS miss with shares slipping marginally after earnings release
XBIO Xenetic Biosciences reports 31 percent narrower Q2 2025 loss than analyst estimates with shares dipping marginally following the earnings release